SarahDAtkinsonMD

Clinical Trials

• Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01

  Completed

  Phase 3

• Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01

  Completed

  Phase 3

• Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01

  Completed

  Phase 3

• Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) Start of enrollment: 2013 Oct 01

  Completed

  Phase 2

• Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30

  Completed

  Phase 3

• Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01

  Completed

  Phase 3

• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Start of enrollment: 2019 Oct 04

  Completed

  Phase 2

• Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® Start of enrollment: 2014 Jun 01

  Terminated

  Phase 2, Phase 3

  Roles: Contact, Principal Investigator

• Join now to see all